Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Maternal Haemoglobin and Short-Term Neonatal Outcome in Preterm Neonates

  • Elodie Savajols,
  • Antoine Burguet,
  • Marianne Grimaldi,
  • Florence Godoy,
  • Paul Sagot,
  • Denis S. Semama

The following information is missing from the Competing Interests section: Author PS received funding from the following commercial companies: Merck Serono, Finox Biotech, MSD France SAS, Teva Santé SAS, Allergan France, Gedeon Richter France, Effik S.A., Karl Storz Endoscopie France, GE Medical Systems SCS, Laboratoires Genevrier, H.A.C. Pharma, and Ipsen. The authors confirm that none of this funding was used to support the research in this study. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Reference

  1. 1. Savajols E, Burguet A, Grimaldi M, Godoy F, Sagot P, Semama DS (2014) Maternal Haemoglobin and Short-Term Neonatal Outcome in Preterm Neonates. PLoS ONE 9(2): e89530. pmid:24586850

Citation: Savajols E, Burguet A, Grimaldi M, Godoy F, Sagot P, Semama DS (2017) Correction: Maternal Haemoglobin and Short-Term Neonatal Outcome in Preterm Neonates. PLoS ONE 12(6): e0179964. https://doi.org/10.1371/journal.pone.0179964

Published: June 14, 2017

Copyright: © 2017 Savajols et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.